Genetic Conditions That Tend to Surface Later in Life

Hereditary hemochromatosis is one of the most common inherited conditions in people of Northern European descent. It causes the body to absorb far more iron from food than it needs, and that excess iron gradually accumulates in organs — particularly the liver, heart, and pancreas.

Most people don't notice symptoms until their 40s or 50s. Men tend to show signs earlier than women, likely because menstruation provides a natural mechanism for iron loss during reproductive years. Symptoms can include joint pain, fatigue, and abdominal discomfort, and are frequently mistaken for other conditions.

Early detection through a simple blood test measuring iron levels and a genetic test for the HFE gene can allow treatment — typically regular blood draws to reduce iron — well before organ damage occurs.

Huntington's disease is caused by a mutation in the HTT gene and follows an autosomal dominant inheritance pattern — meaning one copy of the altered gene is sufficient to cause the disease. Each child of an affected parent has a 50% chance of inheriting it.

What distinguishes Huntington's is its predictable yet delayed onset. Symptoms — which include involuntary movements, cognitive changes, and mood disturbances — most commonly begin between the ages of 30 and 50, though late-onset cases appearing after 60 are also documented.

Predictive genetic testing is available for people with a family history, but the decision to test carries significant emotional weight. Genetic counseling before and after testing is strongly recommended, as the result has implications for the individual and their family members.

Inherited mutations in the BRCA1 and BRCA2 genes significantly elevate lifetime risk for breast, ovarian, and several other cancers. These mutations don't cause cancer directly — they impair the body's ability to repair certain types of DNA damage, increasing vulnerability over time.

Because cumulative risk grows with age, many BRCA-related cancers don't develop until midlife or later. Importantly, these mutations are inherited not just through maternal lines — paternal inheritance is equally possible, and men with BRCA2 mutations face elevated risk for prostate and breast cancers as well.

If multiple relatives on the same side of the family have had breast or ovarian cancer — especially at younger ages — it may be worth discussing genetic testing with a healthcare provider. Our overview of cancer risk and genetics for older adults covers this in more detail.

Familial hypercholesterolemia (FH) is a genetic condition that causes significantly elevated LDL (low-density lipoprotein) cholesterol from birth — but it is frequently undiagnosed until cardiovascular consequences appear in adulthood. People with FH have an inherited defect in how the liver clears LDL from the bloodstream.

Without intervention, the steady accumulation of LDL can lead to premature coronary artery disease, often striking in the 40s or 50s in men and somewhat later in women. Physical signs such as cholesterol deposits around the eyes or tendons may appear in some cases.

FH is underdiagnosed partly because elevated cholesterol is so common that the genetic component is often overlooked. A detailed family history — particularly a pattern of early heart disease — can be a crucial clue. See our reference guide on conditions that run in families for related patterns.

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that reduces levels of a protective protein made by the liver. Without adequate alpha-1 antitrypsin, the lungs become vulnerable to damage — particularly from environmental irritants and smoking — while the liver can also be affected by abnormal protein accumulation.

Lung-related symptoms, which resemble chronic obstructive pulmonary disease (COPD), typically emerge in the 30s to 50s, and the condition is commonly misdiagnosed as COPD or asthma before the genetic cause is identified. People who develop emphysema without a smoking history, or who have a family history of early lung disease, may benefit from testing.

AATD is considered underdiagnosed — current estimates suggest most people who have it are never identified. Understanding its genetic basis is relevant to anyone researching genetic factors and chronic disease risk.

The vast majority of Alzheimer's disease cases are late-onset, appearing after age 65. While most late-onset Alzheimer's does not follow a simple inherited pattern, certain genetic variants — most notably the APOE ε4 allele — are associated with meaningfully increased risk.

Carrying one copy of APOE ε4 is estimated to increase risk several-fold compared to the most common variant; carrying two copies increases it further still. Importantly, the variant is neither necessary nor sufficient to cause the disease — many carriers never develop Alzheimer's, and many without it do.

A smaller subset of cases — often called familial or early-onset Alzheimer's — is linked to rare mutations in genes such as APP, PSEN1, and PSEN2, and can appear before age 65. Genetic counseling is advisable for those with a strong family history before pursuing any genetic testing. See our article on common myths about inherited disease risk for misconceptions worth addressing.